Method may offer safer way to target drugs to living cells
In the realm of
nanotechnology, or study of the tiny, scientists often aim to safely deliver and leave material in the human body without causing harm. A big challenge is how to design a package for this biomaterial that will be compatible with living cells and will not provoke an immune reaction. Previous efforts have relied upon viruses or artificial chemicals to house and deliver drugs or other substances to targeted cells.
Scientists at the David Geffen School of Medicine at UCLA have exploited thousands of tiny capsules in cells to store vast amounts of biomaterial. Dubbed vaults – for their high arches reminiscent of cathedral ceilings – these naturally occurring capsules may prove less likely to elicit an immune response than foreign carriers like viruses.
The UCLA discovery will enable many potential applications, including:
-- Therapeutic delivery, such as homing cancer drugs directly to a tumor cell without harming healthy tissue
-- Enzyme delivery to replace missing or defective enzymes, such as those that cause Tay Sachs disease
-- DNA delivery to correct genetic mutations
-- Timed release of drugs, enzymes and DNA
-- Extracting and imprisoning cellular toxins into the vault
-- Stabilizing proteins in vaults to increase their lifespans
Publication: The Proceedings of the National Academy of Sciences
http://www.pnas.org/cgi/content/abstract/0500929102v1
Source: University of California - Los Angeles
Related stories:
Scientists produce nanoscale droplets with cancer-fighting implications
(PhysOrg.com) -- UCLA scientists have succeeded in making unique nanoscale droplets that are much smaller than a human cell and can potentially be used to deliver pharmaceuticals.
UCLA researchers design nanomachine that kills cancer cells
Researchers from the Nano Machine Center at the California NanoSystems Institute at UCLA have developed a novel type of nanomachine that can capture and store anticancer drugs inside tiny pores and release them into cancer cells in response to light. Known as a "nanoimpeller," the device is the first light-powered nanomachine that operates inside a living cell, a development that has strong implications for cancer treatment.
A new way to fight cancer: the silver shield
Fasting for two days protects healthy cells against chemotherapy, according to a study appearing online the week of Mar. 31 in
PNAS Early Edition. Mice given a high dose of chemotherapy after fasting continued to thrive. The same dose killed half the normally fed mice and caused lasting weight and energy loss in the survivors.
Scientists use nanomaterials to localize and control drug delivery
Using nanotechnology, scientists from UCLA and Northwestern University have developed a localized and controlled drug delivery method that is invisible to the immune system, a discovery that could provide newer and more effective treatments for cancer and other diseases.
UCLA-industry partnership to develop, commercialize new nanotechnology
The California NanoSystems Institute (CNSI) at UCLA and NanoPacific Holdings Inc. have announced a partnership to commercialize a mechanized, nanoparticle-based technology that could lead to prolonged lives of enhanced quality for millions of cancer sufferers.
Researchers outline structure of largest nonvirus particle ever crystallized
Researchers at UCLA's California NanoSystems Institute, the David Geffen School of Medicine at UCLA and the Howard Hughes Medical Institute have modeled the structure of the largest cellular particle ever crystallized, suggesting ways to engineer the particles for drug delivery.
Cancer Drugs That Block Blood Vessel Growth From Inside Cells May Lead to Serious Health Problems in the Long Term
Angiogenesis inhibitors, drugs that block a tumor's development of an independent blood supply, have been touted as effective cancer fighters that result in fewer side effects than traditional chemotherapy. However, a new study by researchers at UCLA's Jonsson Cancer Center has shown that one method of blocking blood-supply development could result in serious and potentially deadly side effects.
Researchers Develop New Nanomaterials to Deliver Anticancer Drugs to Kill Cancer Cells
Researchers at UCLA have successfully manipulated nanomaterials to create a new drug-delivery system that promises to solve the challenge of the poor water solubility of today’s most promising anticancer drugs and thereby increase their effectiveness.